Viking offers asymmetric upside in GLP-1 drugs with positive trial data, strong cash, and buyout potential despite biotech ...

At World Sleep 2025, a discussion group examined the emerging role of GLP-1 receptor agonists in obstructive sleep apnea (OSA ...

One study examines the small molecular cardiac myosin inhibitor for safety and efficacy at 96 weeks, and another compares it ...

The DeMenna family has helped shape Arizona law for generations as one of the Arizona Capitol’s most recognizable and respected public affairs firms.

Two experts discussed innovative trial designs in rare disease research, common challenges and the potential of AI to enhance ...

Placebo-subtracted mean weight loss up to 14.1%after 28 weeks with no plateauPotential for best-in-class tolerability with minimal diarrhea ...

A cannabis extract appears to provide sustained relief from chronic low back pain without signs of addiction or withdrawal, ...

Terns Pharmaceuticals, Inc. is a clinical-stage biotech focused on oncology & obesity, with TERN-601 obesity program. Read ...

A state board unanimously voted Thursday to enact disciplinary sanctions on a Russellville physician after finding he had ...

Building wealth is one of the most important steps toward financial freedom, and one of the best ways to do that is through ...

Half advice show. Half survival guide. Half absurdity-fest. (Wait, how does this work again? We're not numbers people.) Each episode, we answer all your burning questions, from how to survive a public ...

I spoke with a coffee educator to learn about the "Golden Ratio," grind size and other factors that make or break your home brew.